Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PolyRemedy, a manufacturer of point-of-care robotic systems for the fabrication and tracking of customized, nano-material-based wound treatments, has appointed Gary Coughlen as its new CFO.
Subscribe to our email newsletter
As CFO, Mr Coughlen will be responsible for all aspects of PolyRemedy’s finance function, including accounting, financial planning and analysis, and internal policy development. In addition, Mr Coughlen will oversee other important departments, including facilities, legal, intellectual property and human resources.
Most recently, Mr Coughlen served as CFO and board secretary for Refractec, a vision technology firm. Prior to Refractec, he served in financial leadership roles at Scieran Technologies, Precision Capital, and Sierra Capital.
Dan Eckert, president and CEO of PolyRemedy, said: “We are pleased to have Gary on board. Gary is a seasoned professional with more than 20 years of experience in finance, much of it in the medical device setting. As we prepare to launch revolutionary technology to the wound care market, his experience and proven understanding of the challenges and opportunities facing a rapidly growing medical device company will be a great asset to our team.”